APA (7th ed.) Citation

CI, F., & HC, F. (1996). A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 7(5), 465. https://doi.org/10.1093/oxfordjournals.annonc.a010634

Chicago Style (17th ed.) Citation

CI, Falkson, and Falkson HC. "A Randomised Study of CGS 16949A (fadrozole) Versus Tamoxifen in Previously Untreated Postmenopausal Patients with Metastatic Breast Cancer." Annals of Oncology : Official Journal of the European Society for Medical Oncology 7, no. 5 (1996): 465. https://doi.org/10.1093/oxfordjournals.annonc.a010634.

MLA (9th ed.) Citation

CI, Falkson, and Falkson HC. "A Randomised Study of CGS 16949A (fadrozole) Versus Tamoxifen in Previously Untreated Postmenopausal Patients with Metastatic Breast Cancer." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 7, no. 5, 1996, p. 465, https://doi.org/10.1093/oxfordjournals.annonc.a010634.